CrosnierJ., DegosF., JungersP.. Dialysis associated hepatitis. In: Maher JF, ed. Replacement of Renal Function by Dialysis, ed 3. Kluwer Academic Publishers, Dordrecht1989; 42: 881–903.
2.
KeanneW.F., RaijL.R.. Host defences and infectious complications in maintenance hemodialysis patients. In: DrukkerW., ParsonsF.M., MaherJ.F., eds. Replacement of Renal Function by Dialysis, ed 2.Boston, Nijhoff, 1983; 648–58.
3.
RuizP., GomezF., SchreiberA.. Impaired function of macrophage FcY receptors in end-stage renal disease. N Engl J Med1990; 322: 717–22.
4.
Tolkoff-RubinN., RubinR.. Uremia and host defense. N Engl J Med1990; 322: 770–2.
5.
DegastG., HowenB., Van der HemK.. T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients. Infect Immun1976; 14: 1138–45.
AlterM.J., FaveroM.S., MaynardJ.E.. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Innfect Dis1986; 153: 1149–51.
8.
EastwoodJ.B.Hepatitis in a maintenance hemodialysis unit. Ann Intern Med1968; 69: 59–66.
9.
ColemanJ.C.Hepatitis and epidemic hepatitis associated antigen (HEAA) in a hemodialysis unit with observations on haemoglobin levels. Br J Urol1972; 44: 194.
10.
SimonN., MèryJ.P., TrèpoC., Vit-vitskyL., CouroucèA.M.. A non-A non-B hepatitis epidemic in a HB antigen free haemodialysis unit. Demonstration of serological markers of non-A non-B virus. EDTA Proc.1980; 17: 173–8.
11.
GalbraithR.M.Non-A, non-B hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet1975; i: 951–3.
AvramM.M., FeinfeldD.A., GanA.C.. Non-A, non-B hepatitis: a new syndrome in uraemic patients. Proc EDTA1979; 16: 141–7.
14.
AlterM.J.. Non-A, non-B hepatitis: Sorting through a diagnosis of exclusion. Ann Intern Med1989; 110: 583–5.
15.
ChooQ.L., KuoG., WeinerA.J., OverbyL.R., BradleyD.W., HoughtonM.. Isolation of ac-DNA clone derived from bloodborne viral hepatitis genome. Science1989; 244: 359–62.
16.
KuoG., ChooQ.L., AlterH.J.An assay for circulating antibody to a major aetiological virus of human non-A, non-B hepatitis. Science1989; 244: 262–4.
17.
BrechotC.. Les virus “non-A non-B” ont trouvé leur identité. La Press Medicale1990; 34: 1567.
18.
AlterH.J., PurcellR.H., ShihJ.W.Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med1989; 321: 1494–500.
19.
AlterM.J., SamplinerR.E.. Hepatitis C and miles to go before we sleep. Ne Engl J Med1989; 321: 1538–40.
20.
AlterH.J.. Chronic consequences of non-A, non-B hepatitis. In: SeeffL.B., LewisJ.H., eds. Current perspectives in Hepatology.New York, Plenum Medical Books, 1989; 83–97.
ChooQ.L., WeinerA.J., OverbyL.R., KuoG., HoughtonM.. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull1990; 46: 423–41.
23.
ContrerasM., BarbaraJ.A.J.. Screening for hepaatitis C virus antibody. Lancet1989; ii: 505.
24.
EstebanJ.I., EstebanR., ViladomiuL.Hepatitis C virus antibodies among risk groups in Spain. Lancet1989; ii: 294–7.
25.
LudlamC.A., ChapmanD., CohenB., LittonP.A.. Antibodies to hepatitis C virus in haemophilia. Lancet1989; ii: 560–1.
26.
RoggendorfM., DeinhardtF., RasshoferR.Antibodies to hepatitis C virus. Lancet1989; ii: 324–5.
27.
RumiM.G., ColomboM., GringeriA., MannucciP.M.. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med1990; 112: 379–80.
28.
MortimerP.P., CohenB.J., LittonP.A.Hepatitis C virus antibody. Lancet1989; ii: 798.
29.
KatkovW.N., DienstagJ.L., CodyH.. Role of hepatitis C virus in non-B chronic liver disease. Arch Intern Med1991; 151: 1548–52.
30.
Sànchez-TapiasJ.M., BarreraJ.M., CostaJ.Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. Ann Intern Med1990; 112: 921–4.
31.
BruixJ., CalvetX., CostaJ.Prevalence of antibodies to hepatitis C virus in spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet1989; 2: 1004–6.
32.
VargasV., CastellsL., EstebanJ.I.. High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma. Ann Intern Med1990; 112: 232–3.
33.
McFarlaneI.G., SmithH.M., JohnsonP.J., BrayG.P., VerganiD., WilliamsR.. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive results?Lancet1990; 335: 754–7.
34.
LenziM., JohnsonP.J., McFarlaneI.G.Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet1991; 338: 277–80.
35.
YanagiM., KanekoS., UnouraM.Hepatitis C virus in fulminant hepatic failure. N Engl J Med1991; 324: 1895–6.
36.
ColomboM., ChooQ.L., Del NinnoE.Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet1989; 2: 1006–8.
37.
ReadA.E., DoneganE., LakeJ.Hepatitis C in patients undergoing liver transplantation. Ann Intern Med1991; 114: 282–4.
38.
PonzE., CampistolJ.M., BrugueraM.Hepatitis C virus infection among kidney transplant recipients. Kidney Int1001; 40: 748–51.
39.
AlbertiA.Diagnosis of hepatitis C. Facts and perspectives. J Hepatol1991; 12: 279–82.
40.
GilliP., MorettiM., SoffrittiS.Non-A, non-B hepatitis aand anti-HCV antibodies in dialysis patients. Int J Artif Organs1990; 13: 737–41.
41.
TamuraI., KobayashiY., KodaT.. Hepatitis C virus antibodies in haemodialysis patients. Lancet1990; 335: 1409.
ElisafM., TsianosE., MavridisA., DardamanisM., PappasM., SiamopoulosK.C.. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Nephrol Dial Transplant1991; 6: 476–9.
44.
SchlipkoterU., RoggendorfM., ErnstG.Hepatitis C virus antibodies in haemodialysis patients. Lancet1990; 335: 1409.
45.
YamaguchiK., NishimuraY., Ku-kuokaN.Hepatitis C virus antibodies in haemodialysis patients. Lancet1990; 335: 1409–10.
46.
KallinowskiB., TheilmannL., GmelinK.Prevalence of antibodies to hepatitis C virus in hemodialysis patients. Nephron1991; 59: 236–8.
47.
Hsien-HongL., Chiu-ChingH., I-ShyongS., Deng-YnL., Yun-FanL.. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol1991; 11: 192–4.
48.
MarchesiD., AriciC., PolettiE., MingardiG., MinolaE., MeccaG.. Outbreak of non-A, non-B hepatitis in centre hemodialysis patients: a retrospective analysis. Nephrol Dial Transplant1988; 3: 795–9.
49.
CasatiS., GrazianiG., GiachinoG., RumiM.G.. L'epatitie C in dialisi: epidemiologia e proposte di intervento. In: D'AmicoG., BazziC., ColasantiG., eds. Milano. Attualità nefrologiche e dialitiche '90. Wichtig editore, 1991; 255–61.
JeffersL.J., PerezG.O., De MedinaM.D.Hepatitis C infection in two urban hemodialysis units. Kidney Int1990; 38: 320–2.
52.
ZeldisJ.B., DepnerT.A., KuramotoI.K., GishR.G., HollandP.V.. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med112: 958–60.
53.
GrobP., JollerM., JelmelkaH.. Hepatitis C virus (HCV), anti-HCV und non-A, non-B hepatitis. Schweiz Med Wochenschr1990; 120: 117–24.
54.
GetzugT., LindsayK., BrezinaM.Hepatitis C virus antibody in hemodialysis patients: prevalence and risk factors. Gastroenterology1990; 8: 1395.
55.
LaufsR., PolywkaS., KrugerW.Hepatitis-C-Virus antikorper bei hepatitis-patienten und risikogruppen. Dtsch Arztebl1989; 50: 23–4.
56.
AlmrothG., EkermoB., FranzenL., HedJ.. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients. Nephron1991; 59: 232–5.
57.
LeonA., CantonR., EliaM., Ma-teosM.. Second-generation RIBA to confirm diagnosis of HCV infection. Lancet1991; 337: 912.
58.
GilliP., BergamiM., SoffrittiS.. Considerazioni sulla presenza di pazienti anti-HCV positivi nei centri dialisi. Giorn Ital Nefrol1990; 7: 271–2.
59.
Di MaggioA., MontemurroN.E., MarangiA.L.Prevalence of hepatitis C antibodies in hemodialysis patients and staff. A preliminary study. J Nephrol1991; 2: 83–7.
60.
FaganE.A.. Testing for hepatitis C virus. BMJ1991; 303: 535–6.
61.
Editorial.The A to F of viral hepatitis. Lancet1990; 336: 1158–60.
BoudartD., LucasJ.C., MullerJ.Y., Le CarrerD., PlanchonB., Ha-rousseauJ.L.. False positive hepatitis C virus antibody tests in para-proteinaemia. Lancet1990; 336: 63.
64.
CasatoM., TalianiG., PucilloL.P., GoffredoF., LaganàB., BonomoL.. Cryoglobulinaemia and hepatitis C virus. Lancet1991; 337: 1047–8.
65.
IkedaY., TodaG., HashimotoN., KurokawaK.. Antibody to superoxide dismutase, autoimmune hepatitis and antibody tests for hepatitis C virus. Lancet1990; 335: 1345–6.
66.
CottonP.. Tests help nail down HCV – but not entirely. JAMA1991; 265: 312.
67.
GrayJ.J., WreghittT.G., FriendP.J., WightD.G.D., SundaresanV., CalneR.Y.. Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease. Lancet1990; 335: 609–10.
68.
Editorial.Hepatitis C virus upstanding. Lancet1990; 335: 1431–2.
69.
BradleyD.W., MaynardJ.E., PopperH.Posttransfusion non-A, non-B hepatitis: physicoche-mical properties of two distinct agents. J Infect Dis1983; 148: 254–65.
70.
SaikiR.K., ScharfS., FallovnaF.Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science1985; 230: 1350–4.
71.
BrèchotC.. Polymerase chain reaction. A new tool for the study of viral infections in hepatology. J Hepatol1990; 11: 124–9.
GarsonJ.A., TedderR.S., BriggsM.Detection of hepatitis C viral sequences in blood donations by “nested” polymerase chain reaction and prediction of infectivity. Lancet1990; 335: 1419–22.
74.
WeinerA.J., KuoG., BradleyD.W.Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet1990; 335: 1–3.
75.
KanekoS., UnouraM., KobayashiK., KunoK., MurakamiS., HattoriN.. Detection of serum hepatitis C virus RNA. Lancet1990; 335: 976.
76.
CristianoK., Di BisceglieA.M., HoofnagleJ.H., FeinstoneS.M.. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatol1991; 14: 51–5.
77.
EblingF., NaukkarienR., LiikolaJ.. Recombinant immunoblotting assay for hepatitis C virus as predictor of infectivity. Lancet1990; 335: 982–3.
78.
FusconiM., LenziM., BaraldiniG.Anti-HCV testing in autoimmune hepatitis and in primary biliary cirrhosis. Lancet1990; 336: 822–3.
79.
BrillantiS., MasciC., SiringoS.Serological and histological aspects of hepatitis C virus infection in alcoholic patients. J Hepatol1991 (in stampa).
80.
Van der PoelC.L., CuypersH.T.M., ReesinkH.W.Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet1991; 337: 317–9.
81.
BassettiD., CutrupiV., DallagoB., AlfonsiP.. Second-generation RIBA to confirm diagnosis of HCV infection. Lancet1991; 337: 912.
82.
EbelingF., NaukkarinenR., Myl-lylaG., LeikolaJ.. Second generation RIBA to confirm diagnosis of HCV infection. Lancet1991; 337: 912–3.
83.
WeinerA.J., TruettM.A., RosenblattJ.Hepatitis C virus testing in low risk population. Lancet1990; 336: 695.
84.
AlbertiA., ChemelloL., CavallettoD.Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med1991; 114: 1010–12.
85.
FarciP., AlterH.J., WongD.A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med1991; 325: 98–104.
86.
AlbertiA., CavallettoL., RuggeM.Detection of hepatitis C virus in liver of patients with non-A, non-B hepatitis. Proceedings II Int. Symposium on HCV. Los Angeles, November 1990; 45.
87.
KrawczynskiK., BeachM., Di BisceglieA.Hepatocellular HCV-associated antigen and antibody: viral specificity and relation to natural history of infection. Hepatology1990; 12: 905.
88.
SimmondsP., ZhangL.Q., WatsonH.G.Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet1990; 336: 1469–72.
89.
MelbyeM., BiggarR.J., WantzinP., KrogsgaardK., EbbesenP., BeckerN.G.. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. Br Med J1990; 301: 210–2.
90.
TorJ., LlibreJ.M., CarbonellM.Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Br Med J1990; 301: 1130–3.
91.
TedderR.S., GilsonR.J.C., BriggsM.Hepatitis C virus: evidence for sexual transmission. Br Med J1991; 302: 1299–302.
92.
AlterM.J.. Inapparent transmission of hepatitis C: footprints in the sand (editorial). Hepatology1991; 14: 389–91.
93.
HessG., MassingA., RossolS., SchuttH., ClemensR., Meyer zum BuschenfeldK.H.. Hepatitis C virus and sexual transmission. Lancet1989; ii: 987.
94.
KamitsukasaH., HaradaH., Ya-kuraM.Intrafamilial transmission of heppatitis C virus. Lancet1989; ii: 987.
95.
IdeoG., BellatiG., PedraglioE.Intrafamilial transmission of hepatitis C virus. Lancet1990; 335: 353.
96.
AlterM.J., HadlerS.C., JudsonF.N.Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA1990; 264: 2231–5.
97.
Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. JAMA1988; 260: 462–5.
98.
BeccariM., d'AloyaG., RizzoloL.Ricerca di anticorpi anti-HCV con test di II generazione in pazienti dializzati. XI Convegno della Sezione Tosco-Ligure della Società Italiana di Nefrologia. A-lassio, Ottobre 1991 (in stampa).
99.
CanaveseC., PacittiA., TheaA.Discrepancies in results of different methods employed to detect antibodies against hepatitis C virus in dialysis patients. (Abstract) XXVIII Congress of the EDTA, Rimini Novembre 1991.